Biotech Playbook 2021: No Help From Small Caps In Q4

Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but the stock has been choppy over the past month.